期刊文献+

左旋多巴对帕金森病大鼠纹状体多巴胺转运体的影响 被引量:3

Effects of Levodopa on DAT in Rats Striatum with Parkinson′s Disease.
下载PDF
导出
摘要 目的研究左旋多巴(L-dihydroxy-phenylalanine,LD)对帕金森病大鼠纹状体多巴胺转运体的影响。方法采用脑部偏侧注射6-羟基多巴胺(6-hydroxydopamine,6-OHDA)制备PD模型,并将成功模型随机分为PD模型组、LD治疗组,并以正常大鼠作对照,每组9只。其中LD治疗组大鼠给予腹腔注射左旋多巴/苄丝肼(50mg/kg左旋多巴和12.5mg/kg苄丝肼即左旋多巴和苄丝肼溶于含0.05%的乙醇和0.1%的抗坏血酸的注射用水中,配成10mg/ml),每日两次;PD模型组及正常对照组给予腹腔注射等量的含0.05%的乙醇和0.1%的抗坏血酸的注射用水,每日两次。分别于4、6、8周,每组各取3只大鼠,行脑纹状体内多巴胺转运体125I-β-CIT放射自显影,同时用γ-计数器测定纹状体内多巴胺转运体放射活性,计算每克纹状体含放射性占注射剂量的百分比(%ID/g)。结果损毁侧在不同时间段,与正常对照组比较,PD模型组、LD治疗组DAT数量均明显降低,差异均有统计学意义(P<0.01);LD治疗组随时间的延长,呈现递减趋势,但差异尚无统计学意义(P>0.05)。健侧在6周时与正常对照组比较,PD模型组及LD治疗组DAT数量降低,差异有统计学意义(P<0.05);LD治疗组DAT数量有递减趋势,但差异无统计学意义(P>0.05)。纹状体自显影结果与纹状体内标志物放射活度测定结果基本一致。结论长期每日应用50mg/kg LD治疗PD模型大鼠可能会使纹状体内多巴胺转运体的数量减少。 Objective To study the effects of levodopa(L-dihydroxy-phenylalanine) on DAT(dopamine transporter) in rats striatum with Parkinson′s disease.Methods The PD model rats were prepared by injection of 6-OHAD(6-hydroxydopamine) in lateral brain.The successful models of PD were randomly divided into the PD model group and LD treatment group,with normal rats as control(n=9).The rats in LD treatment group were given intraperitoneal injection of levodopa / benserazide(50mg/kg of levodopa and 12.5mg/kg of benserazide,i e.levodopa and benserazide being soluble in water for injection containing 0.05% ethanol and 0.1% ascorbic acid and prepared in 10mg/ml),Bid.The rats in PD model group and nomal control group were given intraperitoneal injection of equal amount of water containing 0.05% ethanol and 0.1% ascorbic acid,twice daily.Three rats from each group were selected and their DAT in striatum were dealt with 125I-β-CIT autoradiography in 4th,6th and 8th weeks.Meanwhile,radioactivity of DAT in striatum was determined with γ-counter and the percentage of radioactivity in each gram of striatum versus total injection dose(% ID/g) was calculated.Results Compared with the normal control group during different phases,the number of DAT of the damaged part in PD model group and LD treatment group were significantly decreased(P0.01).As time going,the number of DAT in the LD treatment group tended to decrease with no significant statistical difference(P〈0.05).Compared with the nomal control group at the 6th week,the number of DAT in the normal part in PD model group and LD treatment group were significantly decreased(P〈0.05).While the number of DAT in LD treatment group was decreased,but the difference showed no significance(P〈0.05).The results from autoradiography and marked radioactivity test in striatum were basically identical.Conclusion The number of DAT in PD model rats′ striatum may be reduced by long-term use of LD in 50mg/kg per day.
机构地区 上海中医药大学
出处 《医学研究杂志》 2011年第4期40-43,共4页 Journal of Medical Research
基金 国家自然科学基金资助项目(30672684 30973722) 上海市教委基金资助项目(05CZ04)
关键词 帕金森病 左旋多巴 多巴胺转运体 放射自显影 放射性活度 Parkinson′s disease Levodopa Dopamine transporter Autoradiography Radioactivity
  • 相关文献

参考文献14

二级参考文献20

  • 1尹伟华,刘春风,苏敏.左旋多巴对健康老年大鼠的神经毒性[J].江苏医药,2004,30(11):814-816. 被引量:2
  • 2Asenbaum S, Brike T, Priker W, et al. Imaging of dopamine transporters with lodine-123-β-CIT and SPECT in Parkinson' s disease[J]. J Nucl Med, 1998,38:1-6. 被引量:1
  • 3Liu ZP, Wang Y, Zhao WJ, et al. Peptide derived from insulin with regadatory activity of dopamine transpextex [ J ]. Neuropharm acology,2001,41:464-471. 被引量:1
  • 4Kuikka JT, Beagstre KA, Vanninen E, et al. Initial experience with single-photon emission tomography using iodine-123-labelled 2β-carbomethoxy-3β-( 4-ildophenyl ) tropane in human brain [ J ].Eur J Nucl Med, 1993, 20:783-786. 被引量:1
  • 5Tsukeda H, Harada N, Nishiyama S, et al. Dese-response and duration effects of acute administration of cocaine and GBR12909 on dopamine synthesis and transporter in the consicious monkey brain:PET studies combined with microdialysis [ J ]. Brain Res, 2000,860(1-2) :141-148. 被引量:1
  • 6Sanghera MK, Manaye K, McMahon A, et al.Dopamine transporter mRNA levels are high in mldbrain neurons vulnerable to MPTP[ J ]. Neuroreport, 1997,8:3327-3331. 被引量:1
  • 7Ben-Shachar D, Zuk R, Glinka Y. Dopamine neurotoxicity: inhibition of mitochondzial respiration[J]. J Neurochem, 1995,64:718-723. 被引量:1
  • 8Amara SG. Neurotransmitter transportem: new insighte into structure, function and pharmacology [ J ]. Rev Bias Biol, 1996,56(Suppl 1 ) :S5-19. 被引量:1
  • 9Jaber M, Jones S, Giroa B, et al. The dopamine transporter: a crucial component regulating dopamine transmission[J]. Mov Disold, 1997,12(5) :629-633. 被引量:1
  • 10Vermeulen BJ, Wolters EC, Tissingh G, et al. Evaluation of[ ^123I] beta-CIT bind with SPECT in controls, early and late Parkinson's disease[J]. Nucl Med Biol, 1995, 22:985-991. 被引量:1

共引文献18

同被引文献31

  • 1王建,谢林,王大为,陈维生,刘晓东,王广基.HPLC法测定人血浆中左旋多巴和卡比多巴浓度及其药代动力学研究[J].中国药科大学学报,2004,35(3):239-243. 被引量:10
  • 2陈燕,任志华,刘,徐明,陆振虞.中枢多巴胺D1和D3受体在运动调控中的作用[J].上海交通大学学报(医学版),2007,27(8):1033-1035. 被引量:4
  • 3Bjorklund A, Dunnett SB. Dopamine neuron systems in the brain: an update [J]. Trends Neurosci, 2007, 30(5): 194- 202. 被引量:1
  • 4Durieux PF, Schiffmann SN, de Kerchove d' Exaerde A. Targeting neuronal populations of the striatum [J]. Neuroa- natomy, 2011, 5: 1-9. 被引量:1
  • 5Ashour R, Tintner R, Jankovic J. Striatal deformities of the hand and foot in Parkinson' s disease [J]. Lancet Neurol, 2005, (4): 423-431. 被引量:1
  • 6Hickey MA, kosmalska A, Enayati J, et al. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington' s disease mice [J]. Neuroscience, 2008(157): 280-295. 被引量:1
  • 7Kim M J, Chung S J, Sung YH, et al. Levodopa-responsive parkinsonism associated with hydrocephalus[J]. Mov Disord, 2006, 21(8): 1279-1281. 被引量:1
  • 8Akiyama T, Tanizaki Y, Akaji K, et al. Severe parkinsonism following endoscopic third ventriculostomy for non-commu- nicating hydrocephalus [J]. Neurol Med Chir (Tokyo), 2011, 51: 60-63. 被引量:1
  • 9Racette BA, Esper GJ, Antenor J, et al. Pathophysiology of parkinsonism due to hydrocephlus [J]. Neurol Neurosurg Psychiatry, 2004,75: 1617-1619. 被引量:1
  • 10Olanow CW, Obeso JA, Stocchi F. Drug insight : Continuous dopaminergic stimulation in the treatment of Parkinson' sdisease [J]. Nat Clin Pract Neurol, 2006, 2(7): 382-392. 被引量:1

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部